Lv41
708 积分 2022-08-30 加入
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
7天前
已完结
Changes in insulin utilization in China from 2020 to 2022
1个月前
已完结
Diabetes in China: epidemiology, pathophysiology and multi-omics
1个月前
已完结
Tirzepatide: A Review in Type 2 Diabetes
1个月前
已完结
Relationship between self-efficacy and adherence to self-management and medication among patients with chronic diseases in China: A multicentre cross-sectional study
1个月前
已完结
Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes
1个月前
已完结
Engineering an Insulin Complex to Treat Diabetes
1个月前
已完结
IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective
2个月前
已完结
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study
4个月前
已完结
Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities
4个月前
已完结
皖公网安备34019202002308
